The patient's view of L-Dopa after one year's therapy.
D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D003072:Cognition Disorders / Q000139:chemically induced; D004295:Dihydroxyphenylalanine / Q000009:adverse effects / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004562:Electrocardiography; D005069:Evaluation Studies as Topic; D005500:Follow-Up Studies; D005684:Gait; D006236:Handwriting; D006801:Humans; D008875:Middle Aged; D009069:Movement Disorders / Q000139:chemically induced; D009325:Nausea / Q000139:chemically induced; D010300:Parkinson Disease / Q000187:drug effects*; D012018:Reflex / Q000187:drug effects; D014839:Vomiting / Q000139:chemically induced
D004295:Dihydroxyphenylalanine